Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

JACKSON, Miss. (WLBT) - On Tuesday, the American Red Cross launched a fight against Sickle Cell Anemia by hosting blood ...

This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Beam Therapeutics' early clinical data shows promising results for sickle cell disease treatment using CRISPR gene editing tool. One patient died ...

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, ...

Ghana on Tuesday unveiled a National Sickle Cell Disease (SCD) Strategy aimed at improving both preventive and treatment services for the condition.

The American Red Cross partnered with several organizations to host a metro-wide blood drive to donate to people with sickle ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.

Based on the initial data generated in the Phase 1b trial, we believe that pociredir has the potential to increase fetal hemoglobin to levels that could ameliorate symptoms of sickle cell disease ...

According to Uganda's Ministry of Health, around 250,000 people in the country live with sickle cell disease, including an estimated 20,000 to 25,000 babies ...

The Pt Deendayal Upadhyay Memorial Health Sciences and Ayush University collaborates with CSIR-CCMB to enhance sickle cell anemia diagnosis and genetic research, improving public health outcomes in ...